Stegent Equity Advisors, Inc. Novo Nordisk A S Transaction History
Stegent Equity Advisors, Inc.
- $86.8 Million
- Q1 2024
A detailed history of Stegent Equity Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Stegent Equity Advisors, Inc. holds 11,218 shares of NVO stock, worth $1.6 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
11,218
Previous 3,193
251.33%
Holding current value
$1.6 Million
Previous $330,000
336.36%
% of portfolio
1.66%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,861Shares Held
310MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.95 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.68 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $321B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...